SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Imclone systems (IMCL) -- Ignore unavailable to you. Want to Upgrade?

To: QuietWon who wrote (385)3/11/1999 6:35:00 AM
From: Greg Rich  Read Replies (2) | Respond to of 2515
 
TO ALL:
So if IMCL "pops," what are your bets about staying up or drifting back? In other words, do we all double our money at high teens, low twenties, and then buy back twice as many shares when we drift back to 10-11 in a few weeks?

Greg



To: QuietWon who wrote (385)3/11/1999 9:34:00 AM
From: CPAMarty  Read Replies (1) | Respond to of 2515
 
CEO said that C225 could be on the market in 18 mos.
Very positive interview!!!!!!!!
CEO answered question on risk of Phase III very effectively; C225 has demonstrated positive results in combination with radiation in about 200 cases.
In in 60% of cases where chemo is failing and C225 was used there was a major response including elimination of the tumor all together.
CEO said that he is confident the the drug has efficacy


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News